focus -WSS

focus

author：fashion 2025-09-06 04:15:27 - browse：9779

Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Report captures long Covid’s disabling effects and policy challenges

WSS

Biotech lab space demand falls sharply

STAT Virtual Event: ASCO Recap, Live!

Microbiome research is starting to find links to chronic diseases

Study: Why relieving medical debt did not improve financial outcomes

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

hotspot

focus

focus

Apple is now the first public company to be valued at $3 trillion

Experts study whether long Covid risk adds up with each reinfection

Apple is now the first public company to be valued at $3 trillion

EpiPen alternative approval delay highlights citizen petition issue

In age of alternative facts, a scholarly course on calling out crap

Curing rare childhood diseases will falter unless Congress steps up

Cancer drug shortages should be causing more outrage

Report captures long Covid’s disabling effects and policy challenges

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Report captures long Covid’s disabling effects and policy challenges

entertainment

Medical student insurance fails on mental health care coverage

Health care court cases: Humana, Sutter, Novant

Biotech lab space demand falls sharply

Lilly's Alzheimer's drug donanemab backed by FDA advisers

What Congress can do to address the rural doctor shortage

Lilly's Alzheimer's drug donanemab backed by FDA advisers

focus

focus

entertainment

focus